New Features
Responding to the need to reduce opioid overdose deaths in the District, School of Medicine students developed the Hoya Drug Overdose Prevention & Education (DOPE) Project.
Typically, liver cancer has a low survival rate. A recent clinical trial of immunotherapy never before tried for the cancer delivered promising results.
The student-driven free clinic in DC has been busy since it reopened in its new location at The Triumph in the Congress Heights neighborhood last September.
Other News & Announcements
Newport Receives High Honor from APA
The American Psychological Association (APA) has selected Elissa Newport, PhD, as recipient of the 2020 APA Distinguished Scientific Contribution Award. The award honors psychologists who have made distinguished theoretical or empirical contributions to basic research in psychology. Newport, a neurology professor, is director of the Center for Brain Plasticity and Recovery.
APS Recognizes Subramanian for Pediatrics Work
The American Pediatric Society (APS) has added Siva Subramanian, MD, to its exclusive membership roster. APS members are “recognized child health leaders of extraordinary achievement who work together to shape the future of academic pediatrics.” Founded in 1888, the APS is the first and most prestigious academic pediatric organization in North America. Subramanian is professor of pediatrics and chief of neonatology at MedStar Georgetown University Hospital.
GUFaculty360 Improved!
A number of enhancements and improvements have been made to GUFaculty360. The interface is cleaner, simpler and easier to navigate. Enhancements include the ability to auto-populate publications with PMID, integration ability with ORCID, and a featured publication section. The “new” GUFaculty360 is expected to be available on Monday, January 6, by 8:00 a.m. Read more about the updates here. For assistance or to delegate, contact
Librarian Scott Dorris, associate director of research services for Dahlgren Memorial Library, reports that 168 Georgetown medical students were named on 128 publications (per PubMed MEDLINE) in 2019.
This is the breakdown by class:  
Class of 2017: 2 
Class of 2018: 2 
Class of 2019: 56 
Class of 2020: 67 
Class of 2021: 29 
Class of 2022: 9 
Class of 2023: 2 
MD/PhD: 1
GUMC in the News
Cancer Today Telling Your Children About Inheritable Cancer Risk with Kenneth Tercyak, Dec. 27, 2019

Medscape Mixed Results With Leukemia Drug in Parkinson's with Charbel Moussa and Fernando Pagan, Dec. 24, 2019

Health Data Management ONC Data Shows Potential Link Between EHRs and Patient Harm with Tom Pacheco, Dec. 20, 2019

Health Exec Certified EHRs Have Some Patient Safety Issues with Tom Pacheco, Dec. 23, 2019

Healthcare Dive ONC Data Reveal Safety Issues in Some EHRs with Tom Pacheco, Dec. 19, 2019

NPR Morning Edition For Her Head Cold, Insurer Coughed Up $25,865 with Ranit Mishori, Dec. 23, 2019

Fox5 Stuff a Santa Fe Event with Georgetown Lombardi, Dec. 19, 2019

AARP Why You Should Talk to Your Doctor About Dementia Risks with Scott Turner, Dec. 17, 2019

The Georgetowner ‘Ending Cancer Starts With Georgetown Lombardi’ with Louis Weiner, Chiranjeev Dash and John J. DeGioia, Dec. 18, 2019

HealthDay Cancer Drug Shows Promise for Parkinson's Patients with Charbel Moussa, Dec. 16, 2019

NPR All Things Considered A Cancer Drug For Parkinson's? New Study Raises Hope, Draws Criticism with Charbel Moussa and Fernando Pagan, Dec. 16, 2019

Independent Cancer Drug Could Help Parkinson’s Disease Sufferers with Fernando Pagan, Dec. 16, 2019

National Catholic Reporter The End of a Well-Lived Life Can Lead You from Death to Dissecting Table with Carlos Suarez-Quian and Mark Zavoyna, Dec. 16, 2019

Press Releases

A clinical trial investigating the repurposed cancer drug nilotinib in people with Parkinson’s disease finds that it is reasonably safe and well tolerated. Georgetown University Medical Center researchers also report finding an increase in dopamine, the chemical lost as a result of neuronal destruction, and a decrease in neurotoxic proteins in the brain among study participants. Finally, they say nilotinib, a tyrosine kinase inhibitor, potentially halts motor and non-motor decline.

A team of neuroscientists at Georgetown University Medical Center have found, in animal models, that they can “switch off” epileptic seizures. These findings provide the first evidence that while different types of seizures start in varied areas of the brain, they all can be controlled by targeting a very small set of neurons in the brain or their tendril-like neuronal axons.

A study by Georgetown Lombardi Comprehensive Cancer Center researchers found that a dding a medication used to treat epilepsy, bipolar disorder and migraines to a blood pressure medicine reversed some aspects of breast cancer in the offspring of mice at high risk of the disease because of the high-fat diet fed to their mothers during pregnancy. However, it had the opposite effect in the offspring whose mothers had not been fed a high-fat diet during pregnancy.
Around Campus
Sandra Jackson, executive director of House of Ruth, will be honored as Georgetown’s 2020 John Thompson Jr. Legacy of a Dream Award recipient January 20 at the Kennedy Center for the Performing Arts. The university presents the award annually to an inspirational emerging local leader at the free Let Freedom Ring! celebration on Martin Luther King Jr. Day. 
Upcoming Events

Thursday, January 9
4:00 - 6:00 p.m.

A presentation by Wendy Walker, chief of the Asian Development Bank’s Social Development Thematic Group

GUMC Social Media